Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-08-29

FDA Approved: CAFFEINE CITRATE — Original Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approved Sagent Pharmaceuticals' caffeine citrate as a generic drug for the treatment of apnea of prematurity under an Original Application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Caffeine citrate (caffeine citrate)

Snippet

ORIG AP for CAFFEINE CITRATE (CAFFEINE CITRATE)